Sign In
Buy TRCK
$0.643
-0.0072 (-1.11%)
At Close: Jul 31, 2026
FDA Grants Three Fast Track Tags to Allogene's Autoimmune Disease Drug
07:50am, Tuesday, 08'th Apr 2025
The FDA's fast track designations will facilitate rapid development and expedited review of ALLO's autoimmune disease candidate.
S&P 500 on Track to Close in a Bear Market
10:38am, Monday, 07'th Apr 2025
Traders are bracing for a wild week on Wall Street. The S&P 500 Index has sunk 20% below its record high set less than two months ago, and is on track to enter its first bear market since the Covid pa
SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloC
Pinnacle Food Group: Not A Buy Yet, But This AgTech IPO Is On The Right Track
04:25pm, Sunday, 06'th Apr 2025
Pinnacle Food Group, a hydroponic farming company, is preparing for its IPO amidst a volatile market, targeting urban households and communities with innovative indoor growing systems. The hydroponic
OKYO Pharma CEO discusses FDA Fast Track filing for urcosimod - ICYMI
09:08am, Saturday, 05'th Apr 2025
OKYO Pharma Ltd (NASDAQ:OKYO) CEO Gary Jacob talked with Proactive about the company's recent developments, including the formal naming of its drug candidate OK-101 as urcosimod. Jacob discussed the c
Penguin Solutions: Growth Momentum Still On Track
09:05am, Saturday, 05'th Apr 2025
I maintain a bullish rating on Penguin Solutions due to strong AI-related demand and solid financial performance, validated by 2Q25 results. PENG reported $366 million in revenue, up 28% y/y, with sig
Fast Track to AV1 with Beamr: High-Quality at a Fraction of the Cost
07:35am, Wednesday, 02'nd Apr 2025
Beamr will showcase its high-performance AV1 solutions, accelerated by NVIDIA GPUs, and with simple, competitive pricing, at the 2025 NAB Show in Las Vegas
VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- Endeavour Silver Corp. ("Endeavour" or the "Company") (NYSE: EXK; TSX: EDR) provides a construction progress update for its Terronera Pr
Intellia: Nex-Z Advancement Remains On Track With Expanded ATTRv-PN Indication
06:24am, Friday, 28'th Mar 2025
Intellia received RMAT designation from the FDA of nex-z for the treatment of patients with Transthyretin [ATTR] Amyloidosis with Cardiomyopathy. Global sales of the Transthyretin Amyloidosis market i
Intelligent Bio Solutions' FDA Clearance Process Remains on Track for 2025 U.S. Launch
09:00am, Tuesday, 25'th Mar 2025
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive t
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) today announced the full and timely repayment of our convertible bond
TSMC: 2nm Is On Track For Mass Production
02:28am, Tuesday, 25'th Mar 2025
Upgrading TSMC to 'Strong Buy' with a fair value of USD$246 per share due to its leading 2nm technology and market recovery potential. TSMC's 2nm production yields reached 60%, with Apple likely to be
PITTSBURGH--(BUSINESS WIRE)--United States Steel Corporation ("U. S. Steel" or the “Company”) (NYSE: X) today highlighted in a letter to stockholders the extraordinary value the U. S. Steel Board
Artemis Gold: First Metal Cast, On Track To Commercial Production (Rating Upgrade)
12:58pm, Wednesday, 19'th Mar 2025
Artemis Gold Inc. receives a 'Buy' rating due to rising gold prices and the first precious metal pour at Blackwater mine. Blackwater mine's transition to production phase and robust growth prospects f
CARDIFF, UNITED KINGDOM / ACCESS Newswire / March 19, 2025 / Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the
